MarkH. Greene
Impact in
- Virology top 5%
- HIV Research and Treatment
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
Papers in
- Oncology 6
- Cutaneous Melanoma Detection and Management 6
-
- Melanoma and MAPK Pathways 1
- Co-authors
- JosephF. Fraumeni (2 shared papers)W P Clark (1 shared paper)Ronald G. Kase (1 shared paper)José Costa (1 shared paper)Sherri J. Bale (3 shared papers)RobertJ. Biggar (1 shared paper)M. G. Sarngadharan (1 shared paper)Stanley H. Weiss (1 shared paper)
- Journals
- The Lancet (6 papers)Recent results in cancer research (1 paper)Plastic & Reconstructive Surgery (1 paper)PubMed (1 paper)
- Partner nations
- United States
In The Last Decade
MarkH. Greene
10 papers receiving 864 citations
Peers
Comparison fields: 5 of 88
- Virology 148
- Reproductive Medicine 139
- Oncology 297
- Immunology 208
- Dermatology 80
Countries citing papers authored by MarkH. Greene
This map shows the geographic impact of MarkH. Greene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MarkH. Greene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MarkH. Greene more than expected).
Fields of papers citing papers by MarkH. Greene
This network shows the impact of papers produced by MarkH. Greene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MarkH. Greene. The network helps show where MarkH. Greene may publish in the future.
Co-authors
The 12 scholars most cited alongside MarkH. Greene, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1982 | 259 | |
| 2 | 1984 | 238 | |
| 3 | 1981 | 169 | |
| 4 | 1982 | 133 | |
| 5 | Cutaneous malignant melanoma and familial dysplastic nevi: evidence for autosomal dominance and pleiotropy. | 1986 | 88 |
| 6 | 1987 | 47 | |
| 7 | 1974 | 23 | |
| 8 | 1986 | 15 | |
| 9 | 1986 | 1 | |
| 10 | Genetic studies of hereditary melanoma (HM) and its precursor, the dysplastic nevus syndrome (DNS) | 1985 | 1 |
About MarkH. Greene
MarkH. Greene is a scholar working on Oncology, Molecular Biology, Dermatology, Epidemiology and Genetics, having authored 10 papers that have together received 974 indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (6 papers), Genetic and rare skin diseases. (2 papers), Cutaneous lymphoproliferative disorders research (2 papers), Intraperitoneal and Appendiceal Malignancies (1 paper), Endometrial and Cervical Cancer Treatments (1 paper), Cancer Genomics and Diagnostics (1 paper), Melanoma and MAPK Pathways (1 paper) and Child Nutrition and Water Access (1 paper). The work is most often cited by research in Virology (148 citations), Reproductive Medicine (139 citations), Oncology (297 citations), Immunology (208 citations) and Dermatology (80 citations). MarkH. Greene has collaborated with scholars based in United States. Frequent co-authors include JosephF. Fraumeni, W P Clark, Ronald G. Kase, José Costa, Sherri J. Bale, RobertJ. Biggar, M. G. Sarngadharan, Stanley H. Weiss, W. A. Blattner and Christine Murray. Their work appears in journals such as The Lancet, Recent results in cancer research, Plastic & Reconstructive Surgery and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.